Impact Analysis of COVID-19 on Implantable Cardioverter Defibrillator (ICD) Market Analysis 2020 by Top Key Players, Future Growth, Revenue Analysis, Demand Forecast To 2025

Implantable Cardioverter Defibrillator (ICD) Market Overview

Implantable Cardioverter Defibrillator (ICD) monitors heart rhythms in the treatments of heart failure cases. ICD sends small electrical impulses to the lower chambers of the heart to help them beat in more synchronized patterns and reduce symptoms. Thus, ICD provides a treatment option to correct heart rates that are too fast and can lead to sudden cardiac arrest. The global implantable cardioverter defibrillator (ICD) market is growing at a rapid pace. 

The growth attributes to the rising prevalence of coronary heart diseases. Besides, reported cases for myocardial ischemia and acute myocardial infarction are providing suitable backgrounds for the market to grow. Also, it is reported that the increased prevalence of diabetes has been fueling market growth. Increased success rates of implantable cardioverter-defibrillators in the treatment of coronary heart disease and myocardial ischemia exponentially increase the adoption of ICDs. 

According to Market Research Future (MRFR), the global implantable cardioverter defibrillator (ICD) market is expected to garner a valuation of 10,425.96 MN by 2025. MRFR also states that in 2018, the global ICD market value had reached USD 6,952.2 MN, which would appreciate further at 5.96%CAGR over the review period (2019-2025). Growing awareness about the benefits that ICDs provide in the treatment of heat-related diseases & disorders is major tailwinds pushing the market growth. 

The rapid increase in the global economy acts as a major driving force behind the growth of the market. Improving economic conditions worldwide are increasingly availing quality care by improving per capita healthcare expenditures. Additionally, substantial investments by public and private organizations made in the developments of advanced implantable cardioverter defibrillator, drive the market growth. Also, technological advances boost market growth, increasing the patient’s preference. 

The subcutaneous ICD technology offers minimally invasive procedures that have a high success rate in the treatment of myocardial ischemia & acute myocardial infarction. Conversely, the high cost of ICDs involved in therapeutic surgeries acts as a major growth impeder for the market. Also, stringent government regulations for product approvals restrict market growth, delaying launches of advanced products. Besides, side-effects related to medications are projected to restrain market growth during the forecast period. 

Implantable Cardioverter Defibrillator (ICD) Market Major Players:

Players leading the global Implantable Cardioverter Defibrillator (ICD) Market include Abbott Laboratories (US), BIOTRONIK (Germany), Boston Scientific Corporation (US), Medtronic (Ireland), MicroPort Scientific Corporation (China), Koninklijke Philips N.V. (Netherlands), Nihon Kohden Corporation (Japan), Progetti Srl (Italy), Fukuda Denshi Co., Ltd (Japan), Getinge (Sweden), and ZOLL Medical Corporation (US), among others. 

Implantable Cardioverter Defibrillator (ICD) Market – Segments

The report is segmented into four dynamics;

By Product: Regular ICD, Cardiac Resynchronization Therapy Defibrillators (CRT-D), Subcutaneous-ICD (S-ICD), and others.

By Indication: Myocardial Ischemia, Acute Myocardial Infarction, Electrolyte Imbalance, Drug Toxicity, and others.

By End User: Ambulatory Surgical Centers, Hospitals & Clinics, and others.

By Regions: Americas, Europe, Asia Pacific, and Rest-of-the-world. 

Implantable Cardioverter Defibrillator (ICD) Market – Regional Analysis

North America dominates the global implantable cardioverter defibrillator (ICD) market. The largest market share attributes to the high adoption rates of cardiac implantable electronic devices in the treatment of prevailing cardiac diseases. Besides, factors such as the presence of many notable players and well-established healthcare sectors in the region positively impact market growth. 

Moreover, high healthcare reimbursements and aging populaces are driving the growth of the ICD market in the region. The North American ICD market is expected to retain its leading position throughout the forecast period.

Europe stands second in the global implantable cardioverter defibrillator market. The market growth is majorly driven by the rapidly growing prevalence of cardiac diseases.  According to the European Cardiovascular Disease Statistics, in 2017, around 45% of deaths occurred in Europe were due to Cardiovascular Diseases (CVD).

Also, factors such as the augmenting demand for cardiac treatments and preventive screening, foster the regional market growth. Germany, heading with its large medical devices industry, dominates the ICD market in Europe. The European ICD market is expected to create a substantial revenue pocket over the assessment period.

The Asia Pacific implantable cardioverter defibrillator market is projected to grow rapidly. Factors such as the changing regulatory scenario, rising healthcare expenditures, and increasing prevalence of cardiovascular diseases drive the regional market growth. Besides, high incidences of diabetes that lead to cardiovascular diseases such as myocardial ischemia in the region are estimated to fuel the market growth.

Furthermore, major ICD players operating at a global level that are focusing on mergers and acquisitions support the growth of the regional market. China provides a huge impetus to the ICD market in the Asia Pacific region, followed by India. The APAC ICD market is estimated to grow at a phenomenal CAGR during the review period. 

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Implantable Cardioverter Defibrillator Market – Competitive Landscape

Highly competitive, the ICD market appears fragmented, due to the presence of several major players. The extensive fragmentation is resulting in higher price competition and a fall in profit margin. Hence, to remain at the front of the competition, players incorporate strategies such as mergers & acquisitions, collaborations, expansion, and product/ technology launch. However, the market is commoditized, and there exists little room for differentiation strategies. 

Manufacturers stay focused on product development and invest substantially to drive R&D, clinical trial, and regulatory approvals to tackle this. Another strategy adopted by manufacturers is to develop close relationships with cardiac hospitals and service agreements. They use a variety of distributions channels to generate significant sales of their product. Companies are also focusing on developing regions, especially India, is experiencing a sharp growth in ICD demand. 

Implantable Cardioverter Defibrillator (ICD) Industry/ Innovation/ Related News:

May 11, 2020 —– Medtronic plc. (Ireland), a medical device company, announced receiving the US FDA approval for its Cobalt & Crome implantable ICDs and cardiac resynchronization therapy-defibrillators (CRT-D). According to the company, its high power devices offer connected health, which further helps clinicians to program & operate from a physical distance, thereby reducing potential exposure to the virus that causes COVID-19.

The devices use the MyCareLinkHeart mobile app, along with other exclusive features such as TriageHF Heart Failure, Risk Status, CareAlert notifications, and Intrinsic ATP (anti-tachycardia pacing). The Cobalt and Crome devices received CE mark approval in January 2020.

Impact Analysis of COVID-19 on Health Insurance Market Analysis 2021 by Top Key Players, Future Growth, Revenue Analysis, Demand Forecast To 2025

Health Insurance Market Analysis

The global health insurance market size is predicted to touch USD 141.3 billion at a 4.1% CAGR between 2019- 2025, reveals the new Market Research Future (MRFR) report. Health insurance, simply put, is an insurance cover that pays for surgical, medical, and dental expenses incurred by the insured.  

Various factors are adding to the global health insurance market share. These factors, as per the new MRFR report, include advancement in research and development activities in the medical sector, increase in per capita disposable income, growing government initiatives, increasing health expenditure, adoption of social media to create health awareness, and rising geriatric population.  

On the contrary, strict rules and regulations, and poor track record of claim settlement are factors that are likely to impede the global health insurance market growth over the forecast period. 

Health Insurance Market Segmentation  

The Market Research Future Report provides an inclusive segmental analysis of the global health insurance market based on service providers, period, type, and demographics.  

Based on demographics, the health insurance market is segmented into senior citizens, adults, and minors. Of these, the adult segment will lead the market over the forecast period for rising awareness among youths regarding health and an increase in the adult population.  

Based on type, the global health insurance market is segmented into preferred provider organizations (PPO), point-of-service (POS) plans, exclusive provider organizations (EPOs), and health maintenance organizations (HMOs). Of these, preferred provider organizations will dominate the market over the forecast period as this is budget-friendly at the start.  

Based on period, the health insurance market is segmented into term insurance and lifetime coverage. Of these, lifetime coverage will have a major share in the market over the forecast period as it offers the policyholder with lifetime coverage.  

Based on service providers, the health insurance market is segmented into both private as well as public. The public segment is further segmented into Medicare and Medicaid. The private segment is further segmented into complimentary private health insurance, supplementary duplicate private health insurance, private health insurance, & primary private health insurance. Of these, the private segment will spearhead the market over the forecast period for the increasing number of private players and hassle-free health insurance schemes offered by them.  

Health Insurance Market Regional Analysis 

Based on the region, the global health insurance market report covers the recent trends and growth opportunities across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will dominate the market over the forecast period for various industry players launching new insurance ideas for people’s welfare and growing awareness about chronic diseases. The US is the major contributor in the region for the expansion of health insurance coverage implemented with the Affordable Care Act.  

The health insurance market in Europe is likely to possess the second-largest share during the forecast period. Factors propelling the health insurance market growth in the region include increasing geriatric population, rise in government spending on healthcare, favorable reimbursement scenario, availability of funds in innovation & research, and technological advances.  

The health insurance market in the Asia Pacific region is predicted to have phenomenal growth over the forecast period. Factors fuelling the health insurance market growth in the region comprise a rise in medical tourism, uses of advanced technologies, lenient regulations, burgeoning demand for chronic disease treatment, and the launch of innovative health insurance policies. China & India are the key contributors in the region as companies in India are concentrating on the rural population while in China on the aging population. They are putting in efforts to boost health insurance penetration. Net profit margins in the region are also high, led by Singapore and Hong Kong.  

The health insurance market in the MEA is predicted to have the smallest share during the forecast period for the low economic developments in African regions.  

Obtain Premium Research Report Details @

Health Insurance Market Key Players 

Eminent players profiled in the health insurance market report include HealthCare International (UK), MultiNational Underwriters (US), CIGNA (US), Expacare (UK), International SOS (Asia), Aetna (US), IHI-Bupa (UK), Allianz SE (Germany), MediCare International (UK), William Russell (UK),, Blue Cross (US), and Integra Global Health Limited (UK).  

Health Insurance Industry News 

April 2020: With an aim to offer health insurance to all, leading insurance regulator IRDAI (Insurance Regulatory & Development Authority of India) has introduced Arogya Sanjeevani, a standard health insurance policy that must be provided by all standalone and general health insurers. Insurance companies such as Manipal Cigna, SBI General, and HDFC Ergo have already launched it, and other insurers soon may follow.  

Acoustic Neuroma Market Analysis 2021 by Future Growth With Impact Analysis of COVID-19, Revenue Analysis, Demand Forecast

Acoustic Neuroma Market Overview

Acoustic neuroma is a non-cancerous (benign) tumor that grows on the vestibulocochlear nerve, which connects the brain and inner ear. It is a non-dangerous condition until its expansion presses other vital brain parts. On observing the current trends, the global acoustic neuroma market is projected to touch a 08 % annual growth mark during the survey periods.

This disease grows slowly and may take several years to develop with symptoms like dizziness, degrading hearing power, loss of balance and others but does not spread to the other body parts. Acoustic neuroma is a very rare disease and is more vibrant among women and middle-aged groups rather than young generations.

The companies are working towards searching for cost-effective measures and treatment methods to help the market expand. However, due to rigid regulations against costly treatments are somehow damaging the market’s growth rates. With the expansion in the market and technologies, the launch of new therapies and procedures will help the market with respect to current and future aspects. 

Global Acoustic Neuroma Market segments

The global acoustic neuroma market is segmented into four parts, which are:

Types: Acoustic neuroma is of two kinds, namely unilateral vestibular schwannomas and bilateral vestibular schwannomas.

Treatments: Middle fossa, surgical removal, radiation therapy, single-fraction stereotactic radiosurgery, and other types of diagnoses are there.

Drugs: Painkillers, corticosteroids, anticonvulsants, and osmotic diuretics drugs are present for acoustic neuroma.

End-Users: Major healthcare facilities like hospitals, clinics, research institutes, and others are the major end-users.

Acoustic Neuroma Market Regional Summary

America, Europe, Asia Pacific, and The Middle East & Africa are the major regions observed for the global acoustic neuroma market.

The American region is the current market leader with The North American region, the largest shareholder. The emphasis towards disease eradication, well-established healthcare facilities, presence of key market leaders and other factors are responsible for the seamless growth in this market. The European region is the second-largest market due to increasing awareness about new diseases, increasing research & development programs and other factors.

The Asia Pacific region is the next market in this tally and will emerge as the fastest-growing market. Increasing patient counts, large population covers, improving healthcare facilities, research & development programs, and other factors are driving the market towards healthier futures.

The rest of the regions are growing at sluggish rates due to the least awareness and struggling economic structures.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Acoustic Neuroma Market Key Players

Some of key the players in the global acoustic neuroma market are GE Healthcare (U.S.), Siemens Healthcare(U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Toshiba Medical Systems Corporation (Japan), F. Hoffmann-La Roche Ag, Merck & Co., Inc., Novartis AG, Pfizer Inc., and others

Acoustic Neuroma Industry News

The global acoustic neuroma market is still in the growing stages and is holding a small share in the market due to less occurrence of this disease. In future aspects, the increasing populations and disease counts will accelerate the market, but costly treatments are hindering the market’s growth rates. The companies are trying to search for cheaper treatment procedures and spreading awareness about this disease. The American region, with The North American region major shareholder, is the current market leader and will stay at the top during the survey period. In contrast, the Asia Pacific region will emerge as the fastest-growing market.

Medical Drones Market Analysis By Industry Size, Share, Revenue Growth, Development And Demand Forecast To 2025

Medical Drones Market Key Players

Zipline (US), DJI (China), DHL (Germany), TUDelft (Netherlands), Flirtey (US), Embention (Spain), Matternet (US), Vayu (US), EHang (China) are the active key players contributing to the market’s expansion.

Medical Drones Market Scope

The medical drones market 2020 has offered some of the past decade’s best investment opportunities. Now, however, the prediction looks more promising as Market Research Future, in its study, has presented a high expected valuation of the market that is going be to USD 398 Million by 2025. This value of the market can be achieved after agreeing to rise at a CAGR of 24.4%, during the forecast period 2019 to2025.

Medical Drones Market: Overview

The market of medical drones has the potential to progress at a rapid pace as the medical industry is advancing to a great extent. Government and private medical providers are increasingly relying on machine learning and technology-oriented medical practices to analyze troves of effects as they seek new medical procedures for curing health issues more efficiently. With this, increasing government initiatives aimed at developing unarmed Arial vehicles has also encouraged technological innovations in a broader way that resulted in the progression of medical drones, which impacted the medical drones’ market.

A prominent case of point occurred in 2018, where the government of Tanzania and DHL partnered to launch a medical drone delivery program. It was aimed towards delivering and distribute blood, life-saving medications, and vaccines. The government’s main intention behind these initiatives was to save the lives of people by providing medications in the hour of need. Renowned industry players such as DHL, Embention, DJI, Matternet, Flirtey, Vayu, and Zipline are implementing strategies of expanding distributional channels in untouched locations, collaborations, and new product launched to garner a higher share of the market.

In 2019, a prominent industry player Zipline planned for expansion in medical drone delivery in Ghana location. The medical drones delivered vaccines to remote areas of the Africa region. All these activities encouraged the use of medical drones, thus resulting in a high expansion of medical drones market at a global level.

Top Market Drivers & Key Challenges

The growth of the medical drones’ market is primarily correlated to the growing applications of drones in the healthcare sector. Medical drones have proved to be beneficial in this sector for its eminent growth. Drones cater to the urgent needs of patients in regards to medicines, blood products, vaccines, and other medical products in local areas. Such rapid delivery helps healthcare professionals to provide quick treatment and save a life. With this, the usage of a medical drone can assist in delivering medicine to the bedside of a patient resulting in less error in medication administration. This array of applications of medical drones will augment business growth is the assessment period.

Further, MRFR, in its study, opines that the growth of the global medical drones market is also driven by more factors such as low cost of equipment and increasing research and development activities by government bodies. Additionally, the increasing penetration of medical drones in the cases of emergency yet another factor boosting the market of medical drones substantially in the forecast period.

On the contrary, the factor of approval regulation for the product has hindered the commercialization of medical drones. This says that drones are not allowed to fly freely without the permission of the government is hampering the growth of the medical drones market for future prospects.

Medical Drones Market: Segmentation

The analysis of the global medical drones market has been carried out by MRFR experts. This segmentation includes primary segments of application and end-user.

The medical drones’ market, considering the segment of the application, includes blood transfer,  pharmaceutical/drug transfer, and vaccines transfer. The blood transfer segment is proliferating due to the rising occurrence of severe bleeding deaths, thus boosting the demand for medical drones. The blood transfer segment is likely to present a growth rate of ~24% during the assessment period. In the MRFR analysis, experts studied that each year, approximately 60,000 Americans die from blood loss or hemorrhaging. Even, around 2 million people die across the globe due to unsuccessful reach of treatment on time. With this, the pharmaceutical/drug transfer segment is rising, with increasing focuses on essential medical drones and the development of medication delivery. 

The medical drones’ market having a segment of end-user, includes emergency medical services and blood banks. Among these, the segment of emergency medical services occupied the largest market share back in 2018, owing to continuous advancements happening in technology. Whereas, the blood banks segment was valued more than USD 31 million in 2018. Medical drones usually transfer blood, plasma, and platelets from blood banks to hospitals and clinics in remote places.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Medical Drones Market: Regional Outlook

In 2018, the Americas was noted as the largest regional market in 2018. The reason behind being the largest regional market was rising technology advancement. Even the governments in this region are also promoting the acceptance of medical drones, resulting as players are actively working to develop advanced drones. Back in October 2019, United Parcel Services (US) received an authority from the Federal Aviation Administration to deliver medical packages at hospitals in the entire country.

The European market also has a promising future to become the second-largest market in 2025. The market growth in this region is mainly attributing to government funding and support to the healthcare sector, coupled with rising research and development.

Asia-Pacific region is also becoming the fastest-growing region for the medical drones market due to the improving healthcare infrastructure, mounting investments in healthcare, and expansions by market players. The participating countries such as India and China are expected to be the fastest-growing as the focus of governments here is towards the adoption of new technologies and faster adoption of best treatment options for people suffering.

The Middle East & Africa region is projected to occupy the least share of the global market for having an underdeveloped healthcare sector.

STD Testing Devices Market Global Trends, Size, Segments, Competitors Strategy, Regional Analysis, Review, Key Players Profile, Statistics And Growth To 2025

STD Testing Devices Market Analysis

The global STD testing devices market is growing at a rapid pace. Market growth attributes to the rising prevalence of sexually transmitted diseases (STD), such as ST infections, chlamydia (CT), gonorrhea (NG), and others. Besides, increasingly emerging therapeutic options for the risk of sexually acquired HIV-1 infection play a causal role in the market development, complementing federal initiative to address the HIV epidemic.

Moreover, the increasing awareness about STDs and government initiatives & funding support promoting the diagnostic & treatment methods escalate the market growth. According to Market Research Future (MRFR), the global STD testing devices market valuation had reached USD 70.29 BN in 2018, which is poised to appreciate at 9.3% CAGR throughout the assessment period (2019-2025). The growing use of STD testing devices for hospitalized patients is a significant growth driver for the market.

Increasing medical clinics with ultrasound machines and prenatal care to provide STD diagnostics & treatment methods boost market growth. Additional factors substantiating market growth include growing healthcare expenditure, global population, and per capita healthcare expenses. The expansion of healthcare infrastructure, including dramatically increasing numbers of hospitals & clinics, pushes the growth of the market. 

On the other hand, unfavorable healthcare reforms are major factors likely to impede the growth of the market. Also, the lack of information about the symptoms and causes hamper the market growth extensively. Nevertheless, rising R&D activities to improve STD diagnostics and treatment procedures would support market growth during the review period. Additionally, government funding to drive R&D required discovering effective STD diagnostic kits, push the growth of the market.  

Global STD Testing Devices Market – Segments

The report is segmented into three dynamics;

By Type                  : Point of Care (PoC) Devices, Laboratory Devices, and others.

By End User          : Hospitals & Clinics, Diagnostics Laboratories, Research & Academic Centers, and others.

By Regions            : Americas, Europe, Asia Pacific, and the Middle East and Africa. 

Global STD Testing Devices Market – Regional Analysis

North America dominates the global STD testing devices market. The largest market share attributes to the rising prevalence of sexually transmitted diseases. Besides, rising numbers of medical clinics with ultrasound machines, and prenatal care to provide testing and treatment for sexually transmitted diseases drive the market growth. The growing use of STD testing devices for hospitalized patients is a significant growth driver for the market.

Moreover, the availability of a wide variety of STD testing kits and surges in awareness about the causes of STIs and its treatments fosters regional market growth. Also, factors such as reforms in the enactment of The Hospital Readmissions Reduction Program (HRRP) boost market growth. The North American STD testing devices market is projected to retain its dominance throughout the estimated period.

Europe stands second in the global STD testing devices market. The market is driven by the growing government support for R&D and the healthcare sector. Also, the significant demand for STI testing kits and increasing per capita healthcare expenses push the growth of the regional market. The proliferating healthcare industry and greater rates of hospital admissions in the region influence market growth.

Additionally, the rising initiatives by public and private organizations to provide a platform to exchange information and improve early diagnosis and care of HIV, sexually transmitted infections, viral hepatitis, and tuberculosis propel the regional market growth. The European STD testing devices market is expected to create a substantial revenue pocket over the projected period.

The Asia Pacific STD testing devices market is growing rapidly. Factors such as increasing awareness for STDs and the diagnostic & treatment methods and government initiatives & funding support foster the regional market growth. Additionally, the growing manufacturing of testing devices, healthcare expenses, and a large population drive regional market growth. Furthermore, improving healthcare infrastructures push the growth of the APAC STD testing devices market. 

Global STD Testing Devices Market – Competitive Landscape

Highly competitive, the STD testing devices market appears fragmented due to the presence of several well-established players. The market is commoditized, and major devices are generic. Thus, there is a lot of overcapacity in the market, especially in the testing kit sector. China has a large manufacturing capacity, which is idle, resulting in a large fall in prices. 

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

STD Testing Devices Market Major Players:

Players leading the global STD testing devices market include Abbott (US), MedMira Inc. (Canada), Qaigen Inc. (US), Thermo Fisher Scientific (US), Cepheid (Danaher Corporation) (US), Hoffmann-La Roche AG (Switzerland), Diasorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), bioMeriuex (France), Becton Dickinson and Company (US), Hologic, Inc. (US), GenePOC Inc. (Canada), Meridian Bioscience (US), and OraSure Technologies (US), among others. 

STD Testing Devices Industry/ Innovation/ Related News:

May 14, 2020 —- Binx Health Inc. (the US), a leading developer of STI test kits, announced the publication of its key pivotal clinical study of its rapid molecular point-of-care platform – the binx Io. Published in The Journal of the American Medical Association, the study shows that the binx Io provides accurate results in diagnostic of two of the most tested-for sexually transmitted infections (STIs) – chlamydia (CT) and gonorrhea (NG).

The standard of care for CT/NG testing often requires 2-10 days for results. However, binx Io provides results in only 30 minutes, enabling a single visit test and treatment. binx received FDA 510(k) clearance for its CT/NG Assay in August 2019 for female swabs and in April 2020 for male urine samples. 

Handheld Surgical Devices Market Size, Growth, Analysis, Outlook By 2020 – Trends, Opportunities And Forecast To 2023

Handheld Surgical Devices Market Overview: 

The global report published by Market Research Future (MRFR) indicates a possibility for the handheld surgical devices market reaching 6.8% CAGR during the forecast period encompassing 2018 to 2023.  

Various factors like growing demand for better healthcare provisions, increasing expenditure in the sector, improved technological support, rising participation from major companies, and others would help the market in its growth.  

But strict government regulations may delay the launching of new products owing to which the market may witness obstacles in the coming years.  

Handheld Surgical Devices Market Segmentation: 

The global market, covering details of the handheld surgical devices market, has been segmented in MRFR’s report based on application, product, and end user. This segmental analysis would facilitate easy market percolation by revealing insights and providing inputs.  

By application, the study with the details of the global market for handheld surgical devices includes urology, neurology, gynecology, orthopedics, wound closure, cardiovascular, and others. Rising incidents of accidents and other trauma-related cases are boosting the demand for easy access to handheld surgical products to provide physicians with an opportunity to work within the golden hour and save lives. In wound closure, cardiovascular, and neurology, this type of surgical instrument would gain better acceptance. Also, the growing number of ambulatory services are expected to promote the demand for such instruments.  

By product, the global study on the handheld surgical devices market can be segmented into retractors, dilators, graspers, forceps and spatulas, cutter devices, auxiliary devices, and others. The auxiliary devices segment has been segmented in the report into cannulas, clamps, and closure devices. The cutter devices segment includes lancets, trocars, and scissors. ‘Others’ segment encompasses blunt dissectors, curettes, punches, and snares. These products require stainless steel primarily. Self-retaining retractors are gaining substantial traction as it provides opportunities to work hands-free. Forceps have a notably big market share.  

By end user, the study with the details of the handheld surgical devices market has been segmented into clinics, research and academic institutes, ambulatory surgical centers, hospitals, and others. The clinics segment is a lucrative option for the market to explore and increase its revenues. 

Handheld Surgical Devices Market Regional Analysis: 

The Americas would explore various possibilities across the globe to increase their market reach as major companies based out their operation from the region, and they are looking for expansion opportunities. The presence of countries like the US and Canada is a game-changer as both these countries are known for their extensive budgetary expenditure for the healthcare sector. Europe would enjoy a similar kind of market scenario and try exploring opportunities to increase market revenue. Developing the healthcare sector in the Asia Pacific region would be the reason behind the rise in the value of the CAGR. The report says it will be the highest.  

Get Premium Research Report, Inclusive of COVID-19 Impact Analysis, Find more information @

Handheld Surgical Devices Market Competitive Landscape: 

Companies making their presence felt through strategic maneuverings in the handheld surgical market are Integra LifeSciences Corporation, B. Braun Melsungen AG, Pelion Surgical, Medtronic, Smith & Nephew, Millennium Surgical Corp, Medicon Eg, Johnson & Johnson, Zimmer Biomet Holdings, Becton, Dickinson, and Company (BD), Elite Medical, Aspen Surgical, KLS Martin, Thompson Surgical, Stryker, CooperSurgical Inc., and others. These companies are banking on their innovations, hike in research-related funding, mergers, collaborations, acquisitions, and other tactical methods. MRFR’s understanding of the moves of these companies would assist in developing future strategies.  

Handheld Surgical Devices Industry News: 

In March 2020, Parvizi Surgical Innovation, LLC, announced that it would invest in a Sydney-based company called Navbit Holdings Pty Ltd. The later company is innovating significantly to boost its market position and ensure the high-level proliferation of handheld surgical devices market. 

CBD (Cannabidiol) Market: Competitive Analysis By Key Vendors, Growth Factors And Developments

CBD (Cannabidiol) Market Analysis  

The CBD (Cannabidiol) Market is anticipated to reach USD 22,07, 162.54 million at a 125.58% CAGR between 2016-2026, states the latest Market Research Future (MRFR) report. Cannabidiol (CBD) is a compound that is primarily found in the leaves and flowers of the hemp plant. It is a powerful CBD found in hemp that has gained ample recognition for supporting the mind and body in various ways owing to its alluring features such as seizure suppressant, anti-anxiety, analgesic, and anti-inflammatory properties.  

Various factors are propelling the CBD market growth. Some of these factors, according to the Market Research Future report, include increasing research and development investments in the pharmaceutical industry, the launch of CBD infused cosmetics, growing number of CBD manufacturers, increasing legalization of medical marijuana, and growing adoption of refined CBD products. Additional factors pushing market growth include growing demand for CBD rich hemp biomass, growing hemp production, increasing use in various pharmaceutical formulations for its healing properties, and growing awareness about the health benefits of CBD consumption. 

On the flip side, the illegal market of CBD, adverse effects, and stringent regulation about the legalization of CBD are factors that may impede the CBD market growth over the forecast period. 

COVID-19 Impact on Cannabidiol (CBD) Market 

Adapting to the effects of the recent novel COVID-19 pandemic, the global COVID 19 Impact on Cannabidiol (CBD) Marketreport has been modified keeping in mind of the changes in production styles, a glut in the supply chain, and new marketing campaigns.

CBD (Cannabidiol) Market Segmentation 

The MRFR report offers a wide segmental analysis of the CBD market on the basis of source, end user, application, product, route of administration, and form.  

Based on form, the CBD market is segmented into liquid and solid. The solid segment is again segmented into hash, capsule/softgel, CBD wax, CBD crystals, and others. The liquid segment is again segmented into e-liquid, cream, tincture, CBD oil, and others. Of these, the liquid segment will have the largest share in the market over the forecast period.  

Based on the product, the CBD market is segmented into therapeutic grade, food-grade, and others. Of these, the therapeutic grade segment will lead the market over the forecast period on account of its increasing use to treat neuropsychiatric disorders and various health benefits.  

Based on the application, the CBD market is segmented into protein bars, energy drinks, diabetes, fibromyalgia, neurogenerative disorder, and others. Of these, the fibromyalgia segment will dominate the market over the forecast period on account of the rising incidence of physiological disorder, particularly in young adults.  

Based on the route of administration, the CBD market is segmented into aerosol spray, inhalation (vapor or smoke), capsules, and tincture. Of these, the tincture segment will lead the market over the forecast period. 

Based on the end user, the CBD market is segmented into food and beverage, healthcare, and others.  

Based on the source, the CBD market is segmented into organic and inorganic. 

CBD (Cannabidiol) Market Regional Analysis 

By region, the CBD market report covers the latest trends and growth opportunities across North America, Latin America, the Asia Pacific, Europe, and the Rest of the World. Of these, North America will remain the driving force in the market over the forecast period on account of the increasing consumption of products that are cannabis-based, growing demand for cannabis, easy availability of cannabis-based products on online platforms, and wide availability of marijuana-derived CBD products. Moreover, shifting preference of consumers towards ingesting vapes and edible products and rising investments being made for the development and launch of CBD based products are also adding market growth. 

The CBD market in the APAC region is predicted to have a rapid growth over the forecast period for the increasing use of CBD products in different food items in Nepal, China, and India and key players laying emphasis on expanding their presence by entering into partnerships and agreements to create new opportunities for the CBD market in the region.  

The CBD market in Europe is predicted to have the second-largest share in the market over the forecast period for the increasing awareness regarding clinical applications of CBD and approval for the sale of CBD products. 

The CBD market in Latin America and the RoW are predicted to have restricted growth over the forecast period on account of the illegal usage of marijuana and adverse effects related to cannabis, and strict government policies. 

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Cannabidiol (CBD) Market Key Players 

Notable players profiled in the CBD market report include Elixinol Global Limited, Canopy Growth Corporation, Medical Marijuana, Inc., CV Sciences, Inc, Isodiol International Inc, ENDOCA, LLC, CBD Health Solutions, Green Roads of Florida, LLC, Freedom Leaf, Inc, Folium Biosciences, and Aphria Inc.

Cannabidiol (CBD) Industry News 

November 2019: Nielsen has expanded its cannabis measurements by joining hands with Denver-based CBD company, Web Holdings. The goal of this analytical relationship is to guide the retail market for consumer goods companies in the US with the evolution of the cannabidiol space. 

Mixed Reality in Healthcare Market Global Projection, Developments Status, Analysis, Trends, Strategic Assessment, Research, Region, Share And Global Expansion By 2024

Mixed Reality in Healthcare Market Outlook

Mixed reality (MR) is a blend of digital and physical content and distinct from its counterparts, virtual and augmented reality. It is also known as hybrid reality. The application of mixed reality in the healthcare sector in aiding doctors, clinicians, and surgeons in diagnosis and improving outcomes of patients can widen its scope vastly. The virtual content will be displayed in the form of videos or 3D models. The global mixed reality in healthcare market report by Market Research Future (MRFR) delineates the various factors, drivers, and challenges in a detailed and comprehensive manner.

The global mixed reality in healthcare market size is predicted to touch USD 2,475 million by 2024. It can exhibit 26.3% CAGR from 2019 to 2024 (forecast period). Transition towards digitization of various processes is one of the primary drivers of the market. Development of sensors and headsets, application in patient care and disease management, and mass acceptance by users can drive the market growth till the end of the forecast period.

Advancements in user interfaces and haptic technology as well as their application in assisting doctors, surgeons, and support staff can be a strong market driver. Benefits of MR which can alleviate doctor workloads and improve service quality can bode well for the mixed reality in healthcare market. According to a randomized controlled trial by Samsung Corporation, virtual reality (VR) therapy can reduce pain levels by 52%.

However, paucity of skilled personnel, high cases of technical glitches, and heavy investment costs can hamper market growth.

Mixed Reality in Healthcare Market Segmentation Analysis

The global mixed reality in healthcare market growth is segmented by component, device type, application, and end-user.

By component, it is segmented into hardware, software, and service. The software segment had accounted for a large market share due to accessibility of the MR software to users for early testing. On the other hand, the hardware segment is expected to grow at a rapid pace during the forecast period.

By device type, it is segmented into augmented reality (AR) in healthcare and virtual reality (VR) in healthcare. The AR in healthcare segment can hold a major market share due to application of AR for alleviating pain levels. On the flip side, the VR in healthcare segment can expand at a robust growth rate due to rising awareness as well as backed up research.

By application, it is segmented into fitness management, patient management, pharmacy management, surgery, surgery simulation, and others. The surgery simulation segment can capture a large share of the mixed reality in healthcare market due to the use of the setup in training upcoming medical students in new surgical techniques.

By end-user, it is segmented into research organizations, hospitals & surgical centers, and others. Hospitals & surgical centers can command the lion’s share of the market due to the rising number of hospitals adopting MR technology.

Mixed Reality in Healthcare Market Regional Analysis

The Middle East & Africa, Latin America, Asia Pacific (APAC), North America, and Europe are regions taken into consideration in the compilation of the global mixed reality in healthcare market report.

The Americas is expected to be the leading region in the global market due to adoption of MR software and increased healthcare budget of the countries. The use of MR in minimally invasive procedures for improving surgical outcomes can lead to significant revenue generation.

The APAC region is projected to exhibit a stupendous growth rate due to a large patient pool and changing government reforms pertaining to healthcare. The region can accrue significant revenue due to increasing collaborations between medtech companies and hospitals.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Mixed Reality in Healthcare Market Competitive Analysis

Major industry participants in the global mixed reality in healthcare market include Echopixel, Medical Realities, Mindmaze, Surgical Theatre LLC, Psious, Osso VR, Atheer, Orca Health, Daqri, Samsung Electronics, Microsoft, Oculus VR, Augmedix, Firsthand Technology, and Google. Development of innovation pilots by companies as well as constant upgrade of the software are certain steps taken to improve their standings in the market.

Mixed Reality in Healthcare Industry News

Microsoft and Philips have decided to collaborate for expanding the application of mixed reality for the Holo Lens 2 headset, the brainchild of Microsoft. The amalgamation of VR and AR can be used in understanding the human condition as well as extend its application beyond pain management.

Gene Expression Analysis Market 2020 Global Industry Trends, Statistics, Size, Share, Growth Factors, Emerging Technologies, Regional Analysis, Competitive Landscape Forecast To 2023

Gene Expression Analysis Market Overview

Market Research Future (MRFR) says that the global gene expression analysis marketcould hold the value of USD 3.250 million by 2023. The market could also achieve a CAGR of 9.1% during the forecast period (2018-2023).

Gene Expression Analysis Market Leading Vendors

Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, GENERAL ELECTRIC COMPANY, Pacific Biosciences of California, Inc., Illumina, Inc., Genotypic Technology Pvt Ltd, Danaher, QIAGEN, Oxford Gene Technology, Thermo Fisher Scientific, BGI, PerkinElmer Inc., Macrogen Inc., Eurofins Scientific, are some of the companies currently leading the worldwide gene expression analysis market.

Gene Expression Analysis Market Growth Boosters and Key Restraints

Personalized medicine, with its ability to affect diagnostic and treatment decisions for every patient, has brought an evolution in modern medicine. Diagnosis, treatment, as well as lifestyle interventions, have now become progressively personalized to every patient genetics, family history along with other factors.

Technologies have made it easier for healthcare professionals to track every patient’s health information and offer personalized care. Personalized medicine has gained immense traction as a result of the boost in the number of genetic disorders. Additionally, the mounting awareness about this form of treatment will drive the market in the near future. The rising technological advancement including molecular services and NGS are uplifting the demand for gene expression services. This factor will ensure the success of the market during the evaluation period.

The downside could be the high cost of instruments, hindering the market growth in the review period. But the development of genomic databases, surge in government funding towards genomics, and increasing personalized medicine are projected to elevate the market position in the subsequent years.

Gene Expression Analysis Market Trends and Opportunities

Rising Investments in Gene Expression Analysis Researches

With gene expression analysis, genetic modifications recorded in animals like mice has given way to advancements in drug discover as well as development, clinical diagnostics and biotechnology, among others. Companies along with research institutes are working on projects based on gene expression analysis. These projects are seeing massive success backed by high investments as the demand for nucleic acid analysis, gene cloning & analysis, and other related microbiological methods is rising.

Gene Expression Analysis Market Segmentation

The global gene expression analysis market has been segmented on the basis of product, services, application, and end-user.

The market, product-wise, include consumables and instruments.

Depending on consumables, the market covers reagents and DNA chips.

Instruments-based segments in the market are polymerase chain reaction (PCR), next-generation sequencing (NGS), microarray, Sanger sequencing, and others.

The services mentioned in the report are gene expression profiling services, sequencing services, bioinformatics solutions, and others.

Gene expression analysis finds applications in drug discovery, diagnosis, research, and others.

The end-users highlighted in the report are pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations, and others.

Gene Expression Analysis Market Regional Outlook

The primary markets for gene expression analysis are Europe, Asia Pacific, Middle East & Africa and the Americas.

During the forecast period, the Americas could very well reach the top position in the global gene expression analysis market, estimates MRFR. The highly-established infrastructure, huge expenditure, and increasing research and development activities in the region play a big role in this growth. The market also gets a boost from the large number of established players based in the region. Case in point is GE Healthcare, which alone generated revenue of USD 19.1 Billion in 2017.

Standing at the second spot, Europe is now an established region in the global gene expression analysis market. The regional market gains from the numerous government initiatives taken in research and development associated with gene expression analysis. Europe is also inundated with esteemed companies such as F. Hoffmann-La Roche Ltd. To illustrate, F. Hoffmann-La Roche, in February 2018, had received an approval from the U.S. Food and Drug Administration (FDA) for its multiplex Factor V and Factor II assessment which could be used on Cobas 4800 systems. This system is known for achieving real-time PCR analysis for high volume labs.

Asia Pacific could expect the fastest growth in the worldwide market. The rising number of global partnerships for the expansion of the region’s healthcare sector, government focus on cancer as well as life science research and internal manufacturing of the sequencing systems favors the regional market. Other factors promoting market growth could be the massive R&D investments and the booming bioresearch centers. On top of this, the surge in the number of research activities in agriculture and the growing approval of gene expression tests add to the market’s strength.

Middle East and Africa could project weak growth in the coming years on account of substandard healthcare amenities and low fund investments associated with research and development activities.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Gene Expression Analysis Industry Update

Amicus Therapeutics Inc. has collaborated with Thermo Fisher Scientific, wherein the process for CLN6 Batten disease gene therapy will now be moved to Thermo Fisher. It will now go through a similar GMP process for commercial and clinical level manufacturing as well as supply.

Leukemia Therapeutics Market 2020 Leading Growth Drivers, Emerging Audience, Segments, Sales, Trends , Analysis

Leukemia Therapeutics Market Overview

Global leukemia therapeutics market is expected to grow significantly over the forecast period. It is anticipated that the market held the value of USD 10.7 billion in 2017 and is projected to grow at a CAGR of 5.3% during the assessment period predicts Market Research Future (MRFR). 

The clinical condition an in which an increased number of abnormal leucocytes or generally called white blood cells of malignant characteristic is called leukemia. Frequent infections, fever with chills and fatigue are early signs of leukemia. Acute, chronic, lymphocytic, and myelogenous leukemias are classified under leukemia. Cancer statistics center of American Cancer Society estimates 61780 new cases of leukemia in 2019. Treatment for such a malicious disease requires intense therapeutic attention. Therefore, the need for accurate treatment in the rising population of leukemia patients is the major factor impelling the global leukemia therapeutics market growth. The traditional therapies involved in the treatment of leukemia are chemotherapy, biological therapy, targeted therapy, radiation therapy, and stem cell transplant. The complex pathology of leukemia demands advancements in medical infrastructure for treatment. Hence, letting the market key players immense opportunity to invest in research and development and bring forth innovation in the leukemia therapy. This generates a lead for clinical researchers to investigate better drug administration methods. Efforts which are being made to deliver more effective leukemia therapies is likely to trigger the leukemia therapeutics market growth.

However, on the flip side, the high cost of existing leukemia therapies and investment required for developing new therapies is curbing the leukemia therapeutics market expansion.

Leukemia Therapeutics Market Segmental Analysis

The global leukemia therapeutics market has been segmented into type, applications, and region.

Based on type, the leukemia therapeutics market is segmented into chemotherapy, biological therapy, targeted therapy, radiation therapy, and stem cell transplant. The Chemotherapy segment which is anticipated to grow with the highest CAGR is further sub-segmented into alkylating agents, antimetabolites, antitumor antibiotics, and others.

Based on applications, the leukemia therapeutics market is segmented into acute lymphocytic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia, and others.

Based on region the  is segmented into North America, Europe, Asia-Pacific, and the Middle East & Africa. The European leukemia therapeutics market has been segmented into Western Europe and Eastern Europe. The Western Europe segment is further divided into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The leukemia therapeutics market in Asia-Pacific has been further divided into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Leukemia Therapeutics Market Regional analysis

Reputed companies in North America manufacturing innovative and effective leukemic therapeutics is anticipated to be a major force allowing North America to dominate the leukemia therapeutics market Growing numbers of leukemia patients in the European region is likely to drive the leukemia therapeutics market in Europe in the upcoming years. Where the leukemia therapeutics market in the Asia-Pacific region is likely to grow at a rapid rate, the Middle East & Africa is expected to show stagnancy in the market proliferation.

Leukemia Therapeutics Industry Update

April 2019: Innovative Cellular Therapeutics (ICT), a clinical stage biotechnology company has achieved promising preclinical and clinical results in late-stage leukemia and lymphoma with novel CAR-T constructs. ICTCAR003, targets CD19 for the treatment of B-cell acute lymphoblastic leukemia.

Create your website at
Get started